Recent Updates
Recently added Catalysts
ATHE Positive Sentiment Score: 65/100

Notification of Issue, Conversion or Payment up of Unquoted Equity Securities Announcement Summary Entity name ALTERITY THERAPEUTICS LIMITED Date of this announcement Monday

Key Takeaway: Alterity Therapeutics Limited has announced the issuance of unquoted equity securities, including options expiring on August 31, 2024, and August 31, 2026. A total of 1.37 billion options will be issued at an exercise price of $0.007, while 457 million options will be available at $0.01. This issuance is aimed at raising additional working capital, which could enhance the company's financial stability. The security codes for the new classes are yet to be confirmed, but this move reflects the company's ongoing efforts to secure funding.

Market Sentiment Analysis

POSITIVE FACTORS

  • Alterity Therapeutics is securing additional working capital.
  • The issuance of new equity securities may strengthen the company’s financial position.
  • Options set to expire in 2024 and 2026 may provide future capital influx.

Full Press Release Details

ALTERITY THERAPEUTICS LIMITED
of this announcement
Monday January 08, 2024
The +securities the subject of this notification
Total number of +securities to be issued/transferred
ASX +security code Security description Total number of +securities to be issued/transferred Issue date
New class - code to be confirmed OPTION EXPIRING 31-AUG-2024 EX $0.007 1,371,428,567 08/01/2024
New class - code to be confirmed OPTION EXPIRING 31-AUG-2026 EX $0.01 457,142,830 08/01/2024
to next page for full details of the announcement
ALTERITY THERAPEUTICS LIMITED
We (the entity named above) give notice of the issue, conversion
or payment up of the following unquoted +securities.
1.2 Registered Number Type Registration number
ABN 37080699065
1.4 The announcement is
1.5 Date of this announcement
The +securities the subject of this notification are:
2.2 a This notification
is given in relation to an issue of +securities in a class which is not quoted on ASX and which:
does not have an existing ASX security code ("new class")
ASX +security code +Security description
New class - code to be confirmed OPTION EXPIRING 31-AUG-2024 EX $0.007
+Security type ISIN code
Options
Date the +securities the subject of this notification
Will all the +securities issued in this class rank
equally in all respects from their issue date?
Have you received confirmation from ASX that the terms
of the +securities are appropriate and equitable under listing rule 6.1?
Please provide a URL link for a document lodged
with ASX setting out the material terms of the +securities being issued.
+Security currency Exercise price Expiry date
AUD - Australian Dollar AUD 0.00700000 31/8/2024
Details of the existing class of +security that
will be issued upon exercise or conversion of this new class of company option
information the entity wishes to provide about the +securities the subject of this notification
provide any further information needed to understand the circumstances in which you are notifying the issue of these +securities to ASX,
including why the issue of the +securities has not been previously announced to the market in an Appendix 3B
the +securities issued for a cash consideration?
describe the consideration being provided for the +securities
raise additional working capital
ASX +security code +Security description
New class - code to be confirmed OPTION EXPIRING 31-AUG-2026 EX $0.01
the +securities the subject of this notification were issued
all the +securities issued in this class rank equally in all respects from their issue date?
you received confirmation from ASX that the terms of the +securities are appropriate and equitable under listing rule 6.1?
provide a URL link for a document lodged with ASX setting out the material terms of the +securities being issued.
+Security currency Exercise price Expiry date
AUD - Australian Dollar AUD 0.01000000 31/8/2026
of the existing class of +security that will be issued upon exercise or conversion of this new class of company option
other information the entity wishes to provide about the +securities the subject of this notification
provide any further information needed to understand the circumstances in which you are notifying the issue of these +securities to ASX,
including why the issue of the +securities has not been previously announced to the market in an Appendix 3B
the +securities issued for a cash consideration?
describe the consideration being provided for the +securities
raise additional working capital
Following the issue, conversion or payment up of the
+securities the subject of this application, the +securities of the entity will comprise:
(A discrepancy in these figures compared to your own
may be due to a matter of timing if there is more than one application for quotation/issuance currently with ASX for processing.)
Quoted +Securities (Total number of each +class of +securities quoted)
ASX +security code and description Total number of +securities on issue
ATH : ORDINARY FULLY PAID 2,802,360,380
Unquoted +Securities (Total number of each +class of +securities issued but not quoted on ASX)
ASX +security code and description Total number of +securities on issue
ATHAAE : OPTION EXPIRING 29-NOV-2026 EX $0.0375 19,250,000
ATHAAF : OPTION EXPIRING 31-JUL-2024 EX $0.07 12,000,000
ATHAAG : OPTION EXPIRING 29-NOV-2026 EX $0.0238 11,900,000
ATHAAB : OPTION EXPIRING 17-SEP-2025 EX $0.09 35,000,000
ATHAAH : OPTION EXPIRING 19-DEC-2026 EX $0.0105 8,000,000
ATHAAD : OPTION EXPIRING 06-JAN-2026 EX $0.032 91,392,720
New class - code to be confirmed : OPTION EXPIRING 31-AUG-2024 EX $0.007 1,371,428,567
New class - code to be confirmed : OPTION EXPIRING 31-AUG-2026 EX $0.01 457,142,830
+securities issued under an exception in Listing Rule 7.2 and therefore the issue did not need any security holder approval under Listing
a Select the number of the applicable exception in Listing Rule 7.2

Frequently Asked Questions

What new options has Alterity Therapeutics issued?

Alterity Therapeutics has issued two new options: one expiring on 31-Aug-2024 at $0.007, and another expiring on 31-Aug-2026 at $0.01.

How many new options were issued by Alterity?

Alterity issued 1,371,428,567 options for 2024 and 457,142,830 options for 2026.

What is the purpose of these new options?

The new options aim to raise additional working capital for Alterity Therapeutics.

Will the new options rank equally with existing options?

Yes, all new options will rank equally in all respects from their issue date.

Is ASX approval required for these new options?

The new options were issued under an exception in Listing Rule 7.2, so no holder approval was necessary.

Last updated: Jan 8, 2024